Teceze delivered specialized field dispatch services supporting a global biopharmaceutical company focused on RNAi therapeutics, achieving perfect SLA across a research-critical dispatch operation spanning EMEA and APAC regions with regulatory-compliant operations.
A biopharmaceutical company focused on RNAi therapeutics with global research facilities across EMEA and APAC requiring perfect-SLA dispatch intake supporting high-value research equipment and specialized operational needs. The organization operates at the frontier of therapeutic innovation, where dispatch failures directly impact research timelines and drug development progress.
The biopharmaceutical company operates research facilities across 12+ countries in EMEA and APAC, each with distinct regulatory requirements and specialized operational needs. Any dispatch failure even a minor delay—directly impacts research timelines and can cost hundreds of thousands in lost research time.
The organization required a dispatch partner capable of: managing perfect SLA across a distributed research estate, understanding high-precision research equipment requirements, navigating regulatory compliance across multiple jurisdictions, and maintaining specialized technical expertise in biopharmaceutical operations.
Teceze implemented a purpose-built dispatch model combining operational perfection with deep biopharmaceutical expertise: specialized dispatch teams trained in research equipment handling, pre-positioned resources in key research hubs, predictive scheduling preventing SLA violations, and regulatory compliance built into every operational procedure. The model prioritized research continuity above all other considerations.
From challenge to transformation, the solution included:
Dispatch personnel trained in high-precision research equipment handling, biopharmaceutical operational requirements, and specialized terminology enabling rapid problem resolution.
Strategic dispatch resource positioning in key research centers enabling sub-hour response times and preventing resource scarcity during peak research activities.
Proactive dispatch scheduling based on research calendars and predictive analytics, with buffer capacity ensuring perfect SLA even during unexpected demand spikes.
All dispatch procedures incorporate regulatory requirements across EMEA and APAC, with documentation and traceability supporting compliance audits and certifications.
Governance reflected the critical importance of research continuity, with dedicated oversight of dispatch performance and research impact:
| Cadence | Forum | Focus |
|---|---|---|
| Daily | Research Dispatch Status | SLA metrics, research impact assessment, urgent dispatch needs |
| Weekly | Operations Review | Dispatch performance, regulatory compliance, team training, emerging issues |
| Monthly | Research Partnerships Review | Research timeline impact, SLA performance, cost optimization, capability expansion |
| Quarterly | Strategic Alignment | Research roadmap alignment, dispatch capability roadmap, regulatory evolution |
“Dispatch is silent when it works perfectly. We have had zero research disruptions due to dispatch failures—that is genuinely remarkable when you consider the complexity of managing operations across EMEA and APAC. Teceze understands that our dispatch needs are research-critical, not just operational. That understanding transforms their service from transactional to mission-enabling.”
— Research Operations Director
Teceze served as the primary dispatch operations partner, managing specialized dispatch execution across all research facilities, maintaining perfect SLA monitoring, sustaining regulatory compliance across jurisdictions, and providing deep biopharmaceutical operational expertise.
With perfect SLA established, focus shifts to expanding dispatch capacity for accelerated research growth and enhancing predictive capabilities for even greater operational efficiency.